PHILIPS FRANCE

Their core work

Philips France is the French subsidiary of Royal Philips, a global health technology company. Within H2020, they contribute medical imaging expertise, smart catheter and implant technology, and patient-specific simulation tools for cardiovascular care. Their work spans from catheterization lab hardware (IVUS, FFR, ICE devices) to advanced computational modeling of aneurysms using CFD and finite element methods, as well as 5G-enabled e-health applications for remote patient monitoring.

What they specialise in

How they've shifted over time

Philips France started with interventional cardiology hardware — smart catheters, intravascular imaging (IVUS, FFR, ICE), and cardiac function assessment from medical imaging (2015–2019). From 2019 onward, their focus shifted toward computational medicine and digital health: patient-specific simulation models using HPC/GPU computing, medical digital twins for aneurysm treatment, and 5G-enabled remote health services. The trajectory shows a clear move from physical medical devices toward software-driven, simulation-based clinical decision support.

Philips France is moving from device-centric R&D toward computational medicine and connected health platforms, making them a strong partner for projects combining clinical data, simulation, and remote care delivery.

How they like to work

Philips France participates exclusively as a consortium partner, never as coordinator — consistent with how large corporates contribute domain expertise and clinical use cases without taking on project management overhead. With 90 unique partners across 17 countries in just 4 projects, they work in large, diverse consortia. This makes them an accessible partner: they are used to integrating into multi-stakeholder projects and bringing industrial-grade medical technology validation to academic-led research.

Despite only 4 projects, Philips France has built a broad network of 90 unique partners across 17 countries, reflecting their participation in large European consortia. Their reach spans well beyond Western Europe, indicating comfort working with partners from diverse research ecosystems.

What sets them apart

Philips France brings something rare to EU consortia: the ability to validate research outputs against real clinical workflows and commercial medical device pipelines. Unlike university partners who develop algorithms or SMEs who build prototypes, Philips can test innovations in the context of actual catheterization labs and imaging systems deployed in hospitals. For any project needing an industrial clinical translation pathway, they are a credible end-user partner with global market access.

Highlights from their portfolio

• MeDiTATe
  Medical digital twin for aneurysm prevention combining CFD, FEM, HPC, augmented reality, and haptic devices — a strong convergence of simulation and clinical application.
• CardioFunXion
  Largest single grant (EUR 504,867) and earliest project, focused on advancing cardiac function assessment from imaging — core to Philips' medical imaging business.
• POSITION-II
  Pilot line project for next-generation smart catheters and implants — directly tied to Philips' commercial catheter lab product portfolio.